Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 336 publications
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.
Journal: Nature reviews. Clinical oncology
Published: July 14, 2026
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.
Journal: Radiology
Published: March 31, 2026
Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 08, 2026
Association Between Proto-Oncogene N-RAS Transcript Level and Overall Survival in Node-Negative Muscle-Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: February 27, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 23, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.
Journal: European urology
Published: February 20, 2026
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus.
Journal: ESMO open
Published: February 16, 2026
Steroid-sparing strategies for managing immune-related adverse events.
Journal: Journal for immunotherapy of cancer
Published: December 31, 2025
A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: December 22, 2025
Last Updated: 09/26/2026